More than 10% of fecal immunochemical test (FIT)–based colorectal cancer screening could not be processed due to unsatisfactory samples. Colorectal cancer (CRC) screening using the fecal ...

For years, the gold standard in screening for colon cancer has been a colonoscopy. But a colonoscopy is a medical procedure that involves length prep work, along with being put under, making it ...

Close to 50,000 Americans will die from colorectal cancer (CRC) in 2016, making it the second-leading cause of cancer-related death in this country (behind only lung cancer).1 What makes the statistic ...

While screening for colorectal cancer (CRC) with a blood-based test would result in better outcomes than no screening at all, it would likely result in worse outcomes than currently available tests -- ...

Results from a new JAMA Network study support the large-scale use of FIT tests. The findings show that those who complete one or more fecal immunochemical test (FIT) screenings are associated with a ...

A newly published study revealed an at-home colon cancer screening test reduces risk of colorectal cancer death by 33%, according to a new study published in JAMA Network Open. Researchers at the Ohio ...

COLUMBUS, Ohio – A noninvasive colorectal cancer screening test that can be done at home could reduce the risk of colorectal cancer death by 33%, according to a new study published in JAMA Network ...

Eleven years ago, my life was forever changed when I lost my beloved husband, Len Atkins, to colorectal cancer. He was only 48, a time when most people wouldn't even consider a colonoscopy. It's a ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Younger vs. older patients achieved a higher rate of ...

The goal of this literature review is to provide information on both the FIT and MT-sDNA test to assist providers in advising patients on other options for colorectal cancer screening in situations ...

VANCOUVER, British Columbia -- The novel multitarget stool RNA test (ColoSense) showed high sensitivity for detecting colorectal neoplasia among adults ages 45 and older, according to the phase III ...